Strategic Initiative

Slingshot members are tracking this corporate initiative:

Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
EBIO

100%
SESN Community voting in process
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Aug 16, 2016
Projected Implementation:
Q3, 2016
Relevance Tracked Until:
Q4, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Ebi-031, Il-6, Antibody, Licensing Deal